Aggressive NK Cell Leukemia

Search Trials
Registry of the German CLL Study Group
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Nov 8, 2016
Disease(s):
CLL
CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Status:
Recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Adult Lymphocyte Depletion Hodgkin Lymphoma
Intervention(s):
6,8-bis(benzylthio)octanoic acidbendamustine hydrochloride
Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Active, not recruiting
Last Changed:
Aug 2, 2018
First Changed:
Jan 1, 1970
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
therapeutic allogeneic lymphocyteslaboratory biomarker analysis
Alemtuzumab (Campath ) to Treat T-Large Granular Lymphocyte Leukemia
Status:
Active, not recruiting
Last Changed:
Aug 10, 2018
First Changed:
Jan 1, 1970
Disease(s):
T-LGL Lymphoproliferative Disorders
Intervention(s):
Alemtuzumab (Campath)
Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer
Status:
Completed
Last Changed:
Jun 7, 2016
First Changed:
Jan 1, 1970
Disease(s):
Anemia
Intervention(s):
cyclosporine

Connect. Empower. Inspire.